Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Roberts

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Transplantation|December 8, 2016
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular CarcinomaJames Salazar, Varun Saxena, James G Kahn, et al.
Hepatology (Baltimore, Md.)|February 4, 2005
Serum sodium predicts mortality in patients listed for liver transplantationScott W Biggins, Harry J Rodriguez, Peter Bacchetti, et al.
Transplantation|August 7, 2018
Should Patients With NAFLD/NASH Be Surveyed for HCC?Maria Reig, Martina Gambato, Nancy Kwan Man, et al.
Clinical Transplantation|September 14, 2006
De novo malignancies following liver transplantation: a case-control study with long-term follow-upFrancis Y Yao, Manjushree Gautam, Caren Palese, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 1, 2019
The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017Philip J Held, Jennifer L Bragg-Gresham, Thomas Peters, et al.
Clinical Transplantation|March 25, 2006
Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent yearsMandana Khalili, Andrew J Vardanian, Chris M Hamerski, et al.
Surgery|February 5, 2008
Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat modelYeonho Park, Ryutaro Hirose, Kim Dang, et al.
Transplantation|April 29, 2016
Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver TransplantationHillary J Braun, Jennifer L Dodge, Garrett R Roll, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 20, 2011
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virusDanielle Brandman, Andrea Pingitore, Jennifer C Lai, et al.
Clinical Neurology and Neurosurgery|August 31, 2010
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitorsMolly M Burnett, Christopher P Hess, John P Roberts, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Transplantation|December 8, 2016
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular CarcinomaJames Salazar, Varun Saxena, James G Kahn, et al.
Hepatology (Baltimore, Md.)|February 4, 2005
Serum sodium predicts mortality in patients listed for liver transplantationScott W Biggins, Harry J Rodriguez, Peter Bacchetti, et al.
Transplantation|August 7, 2018
Should Patients With NAFLD/NASH Be Surveyed for HCC?Maria Reig, Martina Gambato, Nancy Kwan Man, et al.
Clinical Transplantation|September 14, 2006
De novo malignancies following liver transplantation: a case-control study with long-term follow-upFrancis Y Yao, Manjushree Gautam, Caren Palese, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 1, 2019
The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017Philip J Held, Jennifer L Bragg-Gresham, Thomas Peters, et al.
Clinical Transplantation|March 25, 2006
Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent yearsMandana Khalili, Andrew J Vardanian, Chris M Hamerski, et al.
Surgery|February 5, 2008
Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat modelYeonho Park, Ryutaro Hirose, Kim Dang, et al.
Transplantation|April 29, 2016
Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver TransplantationHillary J Braun, Jennifer L Dodge, Garrett R Roll, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 20, 2011
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virusDanielle Brandman, Andrea Pingitore, Jennifer C Lai, et al.
Clinical Neurology and Neurosurgery|August 31, 2010
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitorsMolly M Burnett, Christopher P Hess, John P Roberts, et al.
Pageof 22